ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are for the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 29, 2017 | Series B | $34M | 3 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
The Vinik Family Foundation | — | Series B |
Knoll Capital Management | — | Series B |
American Investment Holdings | — | Series B |